Objectives
After participating in this educational activity, attendees should be able to:
1| Differentiate between the traditional 3-bag and newer 2-bag N-acetylcysteine (NAC) protocols in terms of pharmacokinetics, safety, and clinical outcomes
2| Evaluate the available evidence supporting the use of fomepizole as adjunctive therapy in massive acetaminophen overdose
3| Apply evidence-based strategies to optimize the management of acetaminophen toxicity
Presenter(s):
Daniel O'Connor, PharmD
Daniel O'Connor, PharmD
PGY2 Emergency Medicine Pharmacy Resident
Baystate Medical Center
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Daniel O'Connor PharmD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Session date:
03/09/2026 - 2:00pm to 3:00pm EDT
Location:
Hybrid
United States
See map: Google Maps
Add to calendar:
- 1.00 ACPE Contact Hours
- 1.00 ACPE Technician contact hours
Facebook
X
LinkedIn
Forward